EGFR and central nervous system cancer: Based on the promising results obtained [39] and on the fact that EGFR/PI3K signaling is common to both glioma and TNBC, we hypothesized that such small molecules might also be able to modulate key tumorigenic events in BC cells, particularly in those with brain tropism.